speb/financial-data huggingface dataset:
Financial ratios for GPI — quarterly report dated 2025-12-31
Total revenue: 5579900000
Gross profit: 874400000
Operating income: 215600000
Net income: 43600000
Capital expenditures: 13700000
Operating cash flow: 129200000
Depreciation & amortization: 31500000
Net tangible assets: -349700000
Owner earnings: 61400000
Return on net tangible assets (%): -17.557906777237633
Capex to operating income (%): 6.354359925788497
Buffett classification: The Great
Stock price: 391.95
P/E ratio: 14.344806971239619
Shares outstanding: 11898193
Book value: 2789000000
P/B ratio: 1.6721035304230907
Market cap (USD): 4663496746.349999
Debt to equity: 2.1048045894585874
Current ratio: 1.0762540037025066
Quick ratio: 0.270723751873292
Effective tax rate (%): 31.08974358974359
Interest coverage ratio: 2.8
COGS to revenue (%): 84.32767612322802
SG&A to revenue (%): 11.242136955859424
Free cash flow (dilution-adjusted): 44900000
Buyback yield (%): 6.54015680913074
Retained earnings: 4421900000
Inventory turnover: 1.7164848794367635
Receivables turnover: 8.790012602394455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1037212984956453
FCF margin (%): 0.8046739188874352
Revenue growth (%): -3.5070122952945857
Rule of 40 score: -2.7023383764071505
Financial ratios for GPI — annual report dated 2025-12-31
Total revenue: 22571400000
Gross profit: 3621800000
Operating income: 955200000
Net income: 325200000
Capital expenditures: 124500000
Operating cash flow: 694500000
Depreciation & amortization: 121100000
Net tangible assets: -349700000
Owner earnings: 321800000
Return on net tangible assets (%): -92.02173291392623
Capex to operating income (%): 13.033919597989948
Buffett classification: The Great
Stock price: 391.95
P/E ratio: 14.34039589898524
Shares outstanding: 11898193
Book value: 2789000000
P/B ratio: 1.6721035304230907
Market cap (USD): 4663496746.349999
Debt to equity: 2.1048045894585874
Current ratio: 1.0762540037025066
Quick ratio: 0.270723751873292
Effective tax rate (%): 28.05067792842854
Interest coverage ratio: 3.3586497890295357
COGS to revenue (%): 83.95358728302188
SG&A to revenue (%): 11.277545920944204
Free cash flow (dilution-adjusted): 395500000
Buyback yield (%): 11.896652451494212
Retained earnings: 4421900000
Inventory turnover: 6.912596213475358
Receivables turnover: 35.55671077504726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.750809760310947
FCF margin (%): 1.7522174078701367
Revenue growth (%): 13.22838911630147
Rule of 40 score: 14.980606524171606
Financial ratios for GRG.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3783783783783784
Shares outstanding: 101955014
Market cap (USD): 38577572.86486486
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRG.L — annual report dated 2022-12-31
Total revenue: 1822650602.4096386
Gross profit: 1130481927.7108433
Operating income: 186024096.38554218
Net income: 144939759.03614458
Capital expenditures: 119397590.36144578
Operating cash flow: 303012048.1927711
Depreciation & amortization: 139156626.5060241
Net tangible assets: 521084337.3493976
Owner earnings: 164698795.1807229
Return on net tangible assets (%): 31.606936416184972
Capex to operating income (%): 64.18393782383419
Buffett classification: The Good
Stock price: 0.24783132530120483
P/E ratio: 0.17433205635743976
Shares outstanding: 101955014
Book value: 537349397.5903615
P/B ratio: 0.04702274973049327
Market cap (USD): 25267646.24072289
Debt to equity: 0.6755605381165919
Current ratio: 1.1593609176566981
Quick ratio: 0.9930356411306842
Effective tax rate (%): 18.88064733648011
Interest coverage ratio: 20.586666666666666
COGS to revenue (%): 37.97593865679534
SG&A to revenue (%): 51.81782125859334
Free cash flow (dilution-adjusted): 174216867.4698795
Buyback yield (%): 52.45052080408424
Retained earnings: 506626506.0240964
Inventory turnover: 14.150246305418719
Receivables turnover: 48.48717948717949
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.141996439819252
FCF margin (%): 9.558434690639872
Rule of 40 score: 9.558434690639872
Financial ratios for GRG.L — annual report dated 2023-12-31
Total revenue: 2290632911.392405
Gross profit: 1391265822.78481
Operating income: 217341772.1518987
Net income: 180379746.83544302
Capital expenditures: 238860759.49367088
Operating cash flow: 393417721.5189873
Depreciation & amortization: 158227848.10126582
Net tangible assets: 648860759.4936708
Owner earnings: 99746835.44303793
Return on net tangible assets (%): 15.372610222395625
Capex to operating income (%): 109.9009900990099
Buffett classification: The Gruesome
Stock price: 0.2953164556962025
P/E ratio: 0.16692003344701756
Shares outstanding: 101955014
Book value: 672025316.4556962
P/B ratio: 0.04480336177472217
Market cap (USD): 30108993.374936707
Debt to equity: 0.601996609530985
Current ratio: 1.093211009174312
Quick ratio: 0.9141284403669724
Effective tax rate (%): 24.32288900690388
Interest coverage ratio: 16.66990291262136
COGS to revenue (%): 39.26282051282051
SG&A to revenue (%): 51.248894783377544
Free cash flow (dilution-adjusted): 136835443.0379747
Buyback yield (%): 21.020675933055625
Retained earnings: 637215189.8734177
Inventory turnover: 14.559426229508196
Receivables turnover: 54.34234234234234
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.030331311245913
FCF margin (%): 5.9736958443854995
Revenue growth (%): 25.67591991378213
Rule of 40 score: 31.64961575816763
Financial ratios for GRG.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 682000000
Buffett classification: The Gruesome
Stock price: 0.32412499999999994
Shares outstanding: 101955014
Book value: 713125000
P/B ratio: 0.0463399388785276
Market cap (USD): 33046168.912749995
Debt to equity: 0.7276073619631902
Current ratio: 0.783043197936815
Quick ratio: 0.6050934880722115
Buyback yield (%): 0
Retained earnings: 678750000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRG.L — annual report dated 2024-12-31
Total revenue: 2518000000
Gross profit: 1554500000
Operating income: 244125000
Net income: 191750000
Capital expenditures: 267375000
Operating cash flow: 398250000
Depreciation & amortization: 175000000
Net tangible assets: 682000000
Owner earnings: 99375000
Return on net tangible assets (%): 14.571114369501467
Capex to operating income (%): 109.52380952380953
Buffett classification: The Gruesome
Stock price: 0.32412499999999994
P/E ratio: 0.17233986395176007
Shares outstanding: 101955014
Book value: 713125000
P/B ratio: 0.0463399388785276
Market cap (USD): 33046168.912749995
Debt to equity: 0.7276073619631902
Current ratio: 0.783043197936815
Quick ratio: 0.6050934880722115
Effective tax rate (%): 24.767042667974497
Interest coverage ratio: 14.050359712230216
COGS to revenue (%): 38.264495631453535
SG&A to revenue (%): 52.04030976965846
Free cash flow (dilution-adjusted): 91500000
Buyback yield (%): 18.91293364898526
Retained earnings: 678750000
Inventory turnover: 13.96376811594203
Receivables turnover: 57.55428571428571
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.34621099554235
FCF margin (%): 3.6338363780778398
Revenue growth (%): 9.925950486295315
Rule of 40 score: 13.559786864373155
Financial ratios for GRG.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 735068493.150685
Buffett classification: The Gruesome
Stock price: 0.2513698630136987
Shares outstanding: 101955014
Book value: 779452054.7945206
P/B ratio: 0.03288004405799649
Market cap (USD): 25628417.90273973
Debt to equity: 0.7933216168717047
Current ratio: 0.4895833333333333
Quick ratio: 0.3014112903225806
Buyback yield (%): 0
Retained earnings: 741780821.9178083
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDOBORAX.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8501912171963604
Shares outstanding: 32090000
Market cap (USD): 59372636.1598312
Buyback yield (%): 0
Retained earnings: 23977014.37425821
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDOBORAX.NS — annual report dated 2023-03-31
Total revenue: 27415261.875761267
Gross profit: 13571741.778319124
Operating income: 7363447.015834349
Net income: 6174665.042630938
Capital expenditures: 386138.8550548112
Operating cash flow: 7339183.922046285
Depreciation & amortization: 189464.06820950063
Net tangible assets: 31066004.87210719
Owner earnings: 5977990.255785627
Return on net tangible assets (%): 19.242867824156573
Capex to operating income (%): 5.243995838151053
Buffett classification: The Great
Stock price: 1.2236297198538368
P/E ratio: 6.35925632224721
Shares outstanding: 32090000
Book value: 31066004.872107185
P/B ratio: 1.2639629032365571
Market cap (USD): 39266277.71010962
Debt to equity: 0.00012820919977463412
Current ratio: 9.562349813385143
Quick ratio: 6.274031278581613
Effective tax rate (%): 26.47939656660203
Interest coverage ratio: 654.9718309859155
COGS to revenue (%): 50.49566974839534
SG&A to revenue (%): 2.3784506171824775
Free cash flow (dilution-adjusted): 6733739.3422655305
Buyback yield (%): 0
Retained earnings: 27980012.180267967
Inventory turnover: 1.9634807876360898
Receivables turnover: 17.59641784977172
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.45880364327224
FCF margin (%): 24.562009922725014
Rule of 40 score: 24.562009922725014
Financial ratios for INDOBORAX.NS — annual report dated 2024-03-31
Total revenue: 22940760.283007555
Gross profit: 10662057.800695527
Operating income: 4856541.551744813
Net income: 4674133.589159371
Capital expenditures: 548339.1293920134
Operating cash flow: 8337174.721189591
Depreciation & amortization: 274001.6788583763
Net tangible assets: 35185250.02997962
Owner earnings: 4399796.138625734
Return on net tangible assets (%): 12.504660716854035
Capex to operating income (%): 11.29073278895372
Buffett classification: The Great
Stock price: 1.9131477927063338
P/E ratio: 13.134608050213554
Shares outstanding: 32090000
Book value: 35185250.02997962
P/B ratio: 1.7448479864612694
Market cap (USD): 61392912.66794625
Debt to equity: 0.00011110739995732929
Current ratio: 13.204503269559972
Quick ratio: 11.736388857916795
Effective tax rate (%): 25.377729107157904
Interest coverage ratio: 6749.783333333333
COGS to revenue (%): 56.087881528256226
SG&A to revenue (%): 2.0444007673690425
Free cash flow (dilution-adjusted): 7788835.591797577
Buyback yield (%): 0
Retained earnings: 32146996.04269097
Inventory turnover: 4.793525703742422
Receivables turnover: 14.05823088059142
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.681165902467383
FCF margin (%): 33.95195057056083
Revenue growth (%): -16.321206826442047
Rule of 40 score: 17.630743744118785
Financial ratios for INDOBORAX.NS — quarterly report dated 2024-09-30
Operating income: 1550680.8408982323
Capital expenditures: 0
Net tangible assets: 37686634.01815576
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.5618729096989967
Shares outstanding: 32090000
Book value: 37686634.01815576
P/B ratio: 2.1814233033556514
Market cap (USD): 82210501.67224081
Debt to equity: 0.03034713363178955
Current ratio: 9.45740929776686
Quick ratio: 8.807049579684977
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.0772594866641025
Rule of 40 score: 0
Financial ratios for INDOBORAX.NS — quarterly report dated 2025-03-31
Total revenue: 5858849.66097732
Gross profit: 2699321.9546411033
Operating income: 1075812.4853869535
Net income: 1197217.67594108
Capital expenditures: 0
Depreciation & amortization: 116822.53916296469
Net tangible assets: 39213595.97848959
Owner earnings: 1314040.2151040449
Return on net tangible assets (%): 3.3509811643514014
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.9784105496557358
P/E ratio: 13.25723713704529
Shares outstanding: 32090000
Book value: 39213595.97848959
P/B ratio: 1.619009758076717
Market cap (USD): 63487194.538452566
Debt to equity: 9.718778498603745e-05
Current ratio: 8.682682952890298
Quick ratio: 6.035749835506892
Effective tax rate (%): 19.86760666974437
Interest coverage ratio: 53.40975043528729
COGS to revenue (%): 53.92744120710503
Buyback yield (%): 0
Retained earnings: 36251706.80383446
Inventory turnover: 0.5742093801455357
Receivables turnover: 3.174488354563478
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7152986164590915
Rule of 40 score: 0
Financial ratios for INDOBORAX.NS — annual report dated 2025-03-31
Total revenue: 20488788.870703764
Gross profit: 10430605.564648118
Operating income: 5085761.047463175
Net income: 4969055.412672434
Capital expenditures: 786696.2824409632
Operating cash flow: -12213221.884498479
Depreciation & amortization: 308662.6139817629
Net tangible assets: 39213595.97848959
Owner earnings: 4491021.744213234
Return on net tangible assets (%): 11.452715906688995
Capex to operating income (%): 15.468604897065989
Buffett classification: The Great
Stock price: 1.9784105496557358
P/E ratio: 12.776511683999955
Shares outstanding: 32090000
Book value: 39213595.97848959
P/B ratio: 1.619009758076717
Market cap (USD): 63487194.538452566
Debt to equity: 9.718778498603745e-05
Current ratio: 8.682682952890298
Quick ratio: 6.035749835506892
Effective tax rate (%): 27.541155753452447
Interest coverage ratio: 243.17272219116828
COGS to revenue (%): 49.09115599525508
SG&A to revenue (%): 3.204190775933735
Free cash flow (dilution-adjusted): -12999918.166939443
Buyback yield (%): 0
Retained earnings: 36251706.80383446
Inventory turnover: 1.8279640941201467
Receivables turnover: 11.101397959119039
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.836214603747864
FCF margin (%): -63.44893419018823
Revenue growth (%): -10.6882744166068
Rule of 40 score: -74.13720860679503
Financial ratios for INDOBORAX.NS — quarterly report dated 2025-06-30
Total revenue: 6268242.452609409
Gross profit: 3090861.221624152
Operating income: 1328726.8897729933
Net income: 1194020.5944301428
Capital expenditures: 0
Depreciation & amortization: 100105.31242686638
Owner earnings: 1294125.906857009
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.496840627194009
P/E ratio: 16.77601209317823
Shares outstanding: 32090000
Market cap (USD): 80123615.72665575
Effective tax rate (%): 29.000139159476763
Interest coverage ratio: 56776.5
COGS to revenue (%): 50.690145682902596
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 6.987596803496024
Rule of 40 score: 6.987596803496024
Financial ratios for INDOBORAX.NS — quarterly report dated 2025-09-30
Total revenue: 6521736.18940248
Gross profit: 2807869.222096956
Operating income: 1086313.4160090191
Net income: 1833314.543404735
Capital expenditures: 0
Depreciation & amortization: 97170.23675310034
Net tangible assets: 40687542.27733935
Owner earnings: 1930484.7801578352
Return on net tangible assets (%): 4.744658124098603
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.6007891770011273
P/E ratio: 19.755777325782606
Shares outstanding: 32090000
Book value: 40687542.27733934
P/B ratio: 2.051225510773805
Market cap (USD): 83459324.68996617
Debt to equity: 9.005302044757739e-05
Current ratio: 11.91490693180339
Quick ratio: 11.631827420824447
Effective tax rate (%): 27.90002704608031
Interest coverage ratio: 9635.6
COGS to revenue (%): 56.94598584561557
Buyback yield (%): 0
Inventory turnover: 5.825905489530277
Receivables turnover: 2.8816988970917894
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6477116787177906
Revenue growth (%): 4.044095912204929
Rule of 40 score: 4.044095912204929
Financial ratios for INDOBORAX.NS — quarterly report dated 2025-12-31
Total revenue: 4569923.136905425
Gross profit: 2265489.5844937065
Operating income: 871293.3051130668
Net income: 1032850.6182466303
Capital expenditures: 0
Depreciation & amortization: 89718.16865322492
Owner earnings: 1122568.7868998551
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.154840147042442
P/E ratio: 19.25642983795979
Shares outstanding: 32090000
Market cap (USD): 101238820.31859195
Effective tax rate (%): 23.678015211879753
Interest coverage ratio: 39108
COGS to revenue (%): 50.42608996641007
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -29.927813634483723
Rule of 40 score: -29.927813634483723
Financial ratios for IRISDOREME.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.49756033232229985
Shares outstanding: 170678410
Market cap (USD): 84922806.39984174
Buyback yield (%): 0
Retained earnings: 4252591.322695503
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRISDOREME.NS — annual report dated 2023-03-31
Total revenue: 13711315.468940318
Gross profit: 5682935.444579781
Operating income: 1710633.3739342266
Net income: 1005956.1510353228
Capital expenditures: 127393.42265529842
Operating cash flow: 205870.8891595615
Depreciation & amortization: 645883.0694275275
Net tangible assets: 6933641.900121803
Owner earnings: 1524445.797807552
Return on net tangible assets (%): 21.98622051393759
Capex to operating income (%): 7.447149377327457
Buffett classification: The Great
Stock price: 0.7388550548112058
P/E ratio: 125.3599432200414
Shares outstanding: 170678410
Book value: 6936626.065773447
P/B ratio: 18.179818946544053
Market cap (USD): 126106605.97563946
Debt to equity: 0.6163158014879798
Current ratio: 1.7287717450868727
Quick ratio: 0.7634370937066843
Effective tax rate (%): 26.290752987585563
Interest coverage ratio: 4.817445888930813
COGS to revenue (%): 58.55295243222211
SG&A to revenue (%): 2.0214995305139296
Free cash flow (dilution-adjusted): 78477.4665042631
Buyback yield (%): 0
Retained earnings: 4933788.063337394
Inventory turnover: 1.4673288750768025
Receivables turnover: 3.6019832203812854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.372334341691715
FCF margin (%): 0.5723554875681688
Rule of 40 score: 0.5723554875681688
Financial ratios for IRISDOREME.NS — annual report dated 2024-03-31
Total revenue: 14517663.988487829
Gross profit: 7100539.633049526
Operating income: 2423683.894951433
Net income: 1464432.1861134428
Capital expenditures: 327497.3018347524
Operating cash flow: 205336.37126753808
Depreciation & amortization: 730387.3366111044
Net tangible assets: 8291138.026142223
Owner earnings: 1867322.220889795
Return on net tangible assets (%): 22.52190489414202
Capex to operating income (%): 13.512376862219277
Buffett classification: The Great
Stock price: 0.8474088291746641
P/E ratio: 98.76482704695835
Shares outstanding: 170678410
Book value: 8293752.248471039
P/B ratio: 17.438957332027464
Market cap (USD): 144634391.5834933
Debt to equity: 0.639016448433813
Current ratio: 1.8635846617058023
Quick ratio: 0.7438982269279109
Effective tax rate (%): 25.96066400708145
Interest coverage ratio: 5.403748462649056
COGS to revenue (%): 51.09034319378042
SG&A to revenue (%): 2.924515210287553
Free cash flow (dilution-adjusted): -122160.9305672143
Buyback yield (%): 0
Retained earnings: 6321897.109965224
Inventory turnover: 0.9989227705630502
Receivables turnover: 3.335908825377231
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.932013323274155
FCF margin (%): -0.8414640996243271
Revenue growth (%): 5.880898308948542
Rule of 40 score: 5.039434209324215
Financial ratios for IRISDOREME.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 9008026.755852843
Buffett classification: The Gruesome
Stock price: 0.831820353559484
Shares outstanding: 170678410
Book value: 9009531.772575252
P/B ratio: 15.758174668225772
Market cap (USD): 141973775.35117057
Debt to equity: 0.6202713058050214
Current ratio: 1.9455202168866645
Quick ratio: 0.853064754891403
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRISDOREME.NS — quarterly report dated 2024-12-31
Total revenue: 3890395.150949994
Gross profit: 1940855.5775731436
Operating income: 495115.9808835528
Net income: 276722.22869798343
Capital expenditures: 0
Depreciation & amortization: 208940.4359482457
Owner earnings: 485662.6646462291
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6714069238839026
P/E ratio: 103.52860589721989
Shares outstanding: 170678410
Market cap (USD): 114594666.23149551
Effective tax rate (%): 25.29422871168733
Interest coverage ratio: 3.894022735606894
COGS to revenue (%): 50.11160814604637
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRISDOREME.NS — annual report dated 2025-03-31
Total revenue: 17099988.309562776
Gross profit: 8141571.1947626835
Operating income: 2538064.063595978
Net income: 1534054.2436287117
Capital expenditures: 98760.81365443066
Operating cash flow: 296329.20271218143
Depreciation & amortization: 736263.7362637363
Net tangible assets: 9606862.28664952
Owner earnings: 2171557.1662380174
Return on net tangible assets (%): 22.604229158731574
Capex to operating income (%): 3.8911867935478526
Buffett classification: The Great
Stock price: 0.5095110281246353
P/E ratio: 56.68804249846699
Shares outstanding: 170678410
Book value: 9619347.673602993
P/B ratio: 9.040377280095296
Market cap (USD): 86962532.15777804
Debt to equity: 0.6128780964441403
Current ratio: 2.011607394527897
Quick ratio: 0.9077869306755091
Effective tax rate (%): 26.34335269849289
Interest coverage ratio: 5.167836995072719
COGS to revenue (%): 52.38843999554259
SG&A to revenue (%): 2.0408372546459264
Free cash flow (dilution-adjusted): 197568.38905775076
Buyback yield (%): 0
Retained earnings: 7697054.009819967
Inventory turnover: 1.0993420901620532
Receivables turnover: 2.76141059646407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.19107163076476
FCF margin (%): 1.1553714861153745
Revenue growth (%): 17.78746445104854
Rule of 40 score: 18.942835937163913
Financial ratios for IRISDOREME.NS — quarterly report dated 2025-03-31
Total revenue: 4699976.619125555
Gross profit: 2263818.09679682
Operating income: 829003.9747486556
Net income: 523977.08674304414
Capital expenditures: 0
Depreciation & amortization: 118424.12906242693
Net tangible assets: 9606862.28664952
Owner earnings: 642401.2158054711
Return on net tangible assets (%): 6.6868993916796775
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5095110281246353
P/E ratio: 41.49157203529782
Shares outstanding: 170678410
Book value: 9619347.673602993
P/B ratio: 9.040377280095296
Market cap (USD): 86962532.15777804
Debt to equity: 0.6128780964441403
Current ratio: 2.011607394527897
Quick ratio: 0.9077869306755091
Effective tax rate (%): 26.80612711476909
Interest coverage ratio: 6.502200623509995
COGS to revenue (%): 51.833417902874366
Buyback yield (%): 0
Retained earnings: 7697054.009819967
Inventory turnover: 0.29895589450488913
Receivables turnover: 0.7589809422225579
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.574864179490302
Revenue growth (%): 20.809749055385023
Rule of 40 score: 20.809749055385023
Financial ratios for IRISDOREME.NS — quarterly report dated 2025-06-30
Total revenue: 4376199.3915282
Gross profit: 1870723.1453311492
Operating income: 489667.6807863328
Net income: 307758.0154458226
Capital expenditures: 0
Depreciation & amortization: 126620.64123566581
Owner earnings: 434378.65668148844
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7700678680084251
P/E ratio: 118.57376521531117
Shares outstanding: 170678410
Market cap (USD): 131433959.30376786
Effective tax rate (%): 27.599306301098352
Interest coverage ratio: 7.2287096216963205
COGS to revenue (%): 57.25233295007888
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -6.888911452874305
Rule of 40 score: -6.888911452874305
Financial ratios for IRISDOREME.NS — quarterly report dated 2025-12-31
Total revenue: 5421410.270691768
Gross profit: 2021744.4580594855
Operating income: 537250.7519215774
Net income: 335435.000556979
Capital expenditures: 0
Depreciation & amortization: 133808.6220340871
Owner earnings: 469243.62259106606
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.4229698117411162
P/E ratio: 49.998059670962036
Shares outstanding: 170678410
Market cap (USD): 72191814.94597304
Effective tax rate (%): 27.52304618865381
Interest coverage ratio: 6.859479448158157
COGS to revenue (%): 62.70814498232925
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 23.883986666306185
Rule of 40 score: 23.883986666306185
Financial ratios for ISRG.TO — quarterly report dated 2025-12-31
Total revenue: 2092116788.3211677
Gross profit: 1390000000
Operating income: 630875912.4087591
Net income: 583576642.3357664
Capital expenditures: 118613138.68613137
Operating cash flow: 651459854.0145985
Depreciation & amortization: 161240875.91240874
Net tangible assets: 12731824817.518248
Owner earnings: 626204379.5620438
Return on net tangible assets (%): 4.918418125738135
Capex to operating income (%): 18.80134212657642
Buffett classification: The Great
Stock price: 21.781021897810216
P/E ratio: 94.23992455934
Shares outstanding: 8959329652
Book value: 13096131386.861313
P/B ratio: 14.900839765221802
Market cap (USD): 195143355339.91238
Debt to equity: 0
Current ratio: 4.874638620277141
Quick ratio: 3.9574818064001596
Effective tax rate (%): 16.335286730849727
COGS to revenue (%): 33.56011443723397
R&D to revenue (%): 12.312469471774476
SG&A to revenue (%): 23.972507152327125
Free cash flow (dilution-adjusted): 384452554.74452555
Buyback yield (%): 0.0751833585169199
Retained earnings: 5118102189.781021
Inventory turnover: 0.5227717391304347
Receivables turnover: 1.7603488514924455
Capitalized R&D asset: 491833203.80192196
ROCI (R&D-adjusted, %): 4.637136595568108
Rosenberg metric: 0.8187613843351543
FCF margin (%): 18.376247296071455
Revenue growth (%): 16.08488027489613
Rule of 40 score: 34.461127570967584
Financial ratios for ISRG.TO — annual report dated 2025-12-31
Total revenue: 7346496350.364963
Gross profit: 4848394160.583941
Operating income: 2150000000
Net income: 2099708029.1970801
Capital expenditures: 394014598.54014593
Operating cash flow: 2212043795.6204376
Depreciation & amortization: 494233576.6423357
Net tangible assets: 12731824817.518248
Owner earnings: 2199927007.29927
Return on net tangible assets (%): 17.278960705399427
Capex to operating income (%): 18.32626039721609
Buffett classification: The Great
Stock price: 21.781021897810216
P/E ratio: 92.93832886591113
Shares outstanding: 8959329652
Book value: 13096131386.861313
P/B ratio: 14.900839765221802
Market cap (USD): 195143355339.91238
Debt to equity: 0
Current ratio: 4.874638620277141
Quick ratio: 3.9574818064001596
Effective tax rate (%): 13.130398018964787
COGS to revenue (%): 34.00399415779904
R&D to revenue (%): 13.03367214124614
SG&A to revenue (%): 23.696682464454977
Free cash flow (dilution-adjusted): 1242700729.9270072
Buyback yield (%): 0.8585490686760509
Retained earnings: 5118102189.781021
Inventory turnover: 1.8599999999999999
Receivables turnover: 6.181488760594521
Capitalized R&D asset: 1743827339.0842733
ROCI (R&D-adjusted, %): 14.916075725487596
Rosenberg metric: 1.1342038327381787
FCF margin (%): 16.91555635041283
Revenue growth (%): 25.78261492345514
Rule of 40 score: 42.69817127386797
Financial ratios for JEV.V — annual report dated 2021-12-31
Capital expenditures: 2624.4094488188975
Buffett classification: The Gruesome
Stock price: 0.48031496062992124
Shares outstanding: 336444046
Market cap (USD): 161599108.7086614
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JEV.V — annual report dated 2022-12-31
Total revenue: 17151.470588235294
Gross profit: -387886.76470588235
Operating income: -4911605.882352941
Net income: -3320077.205882353
Capital expenditures: 46066.17647058823
Operating cash flow: -2399839.705882353
Depreciation & amortization: 392002.2058823529
Net tangible assets: 10950340.44117647
Owner earnings: -2974141.1764705884
Return on net tangible assets (%): -27.1602622078027
Buffett classification: The Gruesome
Stock price: 0.2647058823529411
Shares outstanding: 336444046
Book value: 12970489.705882352
P/B ratio: 6.866257179051133
Market cap (USD): 89058718.05882351
Debt to equity: 0.17375148994895992
Current ratio: 0.38581247333698176
Quick ratio: 0.38581247333698176
Interest coverage ratio: -10.057613317433358
COGS to revenue (%): 2361.5364828946235
R&D to revenue (%): 1494.1781702820886
SG&A to revenue (%): 24880.93114978993
Free cash flow (dilution-adjusted): -4206727.94117647
Buyback yield (%): 0
Retained earnings: -29094647.058823526
Receivables turnover: 0.4279136321109501
Capitalized R&D asset: 256273.5294117647
ROCI (R&D-adjusted, %): -30.66723129554661
FCF margin (%): -24526.922747149103
Rule of 40 score: -24526.922747149103
Financial ratios for JEV.V — annual report dated 2023-12-31
Total revenue: 55303.030303030304
Gross profit: -421165.1515151515
Operating income: -3646556.818181818
Net income: -5546691.666666666
Capital expenditures: 1321.969696969697
Operating cash flow: -2422312.878787879
Depreciation & amortization: 476468.1818181818
Net tangible assets: 8550765.15151515
Owner earnings: -5071545.454545454
Return on net tangible assets (%): -59.311013279867744
Buffett classification: The Gruesome
Stock price: 0.15151515151515152
Shares outstanding: 336444046
Book value: 10136040.15151515
P/B ratio: 5.029219482564953
Market cap (USD): 50976370.60606061
Debt to equity: 0.29303296898936915
Current ratio: 0.13675694347303544
Quick ratio: 0.13675694347303544
Interest coverage ratio: -6.300012172153516
COGS to revenue (%): 861.5589041095891
R&D to revenue (%): 798.4931506849314
SG&A to revenue (%): 5033.721917808219
Free cash flow (dilution-adjusted): -2638613.6363636362
Buyback yield (%): 0
Retained earnings: -35522994.696969695
Receivables turnover: 0.8166644292298744
Capitalized R&D asset: 613294.1737967914
ROCI (R&D-adjusted, %): -25.098076506201846
Rosenberg metric: -0.12985495179956513
FCF margin (%): -4771.191780821918
Revenue growth (%): 222.43900030918812
Rule of 40 score: -4548.752780512729
Financial ratios for JEV.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0962962962962963
Shares outstanding: 336444046
Market cap (USD): 32398315.54074074
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JEV.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -172351.74825174827
Operating income: -959772.027972028
Net income: -1957290.2097902098
Capital expenditures: 0
Operating cash flow: -358024.47552447557
Depreciation & amortization: 172351.74825174827
Net tangible assets: 7824802.097902099
Owner earnings: -1784938.4615384615
Return on net tangible assets (%): -22.81129208388567
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 336444046
Book value: 8519700.699300699
P/B ratio: 3.313856647513472
Market cap (USD): 28233066.7972028
Debt to equity: 0.22242245287187937
Current ratio: 0.03531410362059385
Quick ratio: 0.03531410362059385
Interest coverage ratio: -1.3164170142808775
Free cash flow (dilution-adjusted): -358024.47552447557
Buyback yield (%): 0
Retained earnings: -37875327.97202797
Receivables turnover: 0
Capitalized R&D asset: 12866.433566433567
ROCI (R&D-adjusted, %): -11.12568953390571
Rule of 40 score: 0
Financial ratios for JEV.V — annual report dated 2024-12-31
Total revenue: 7788.811188811189
Gross profit: -666444.055944056
Operating income: -3311657.342657343
Net income: -5084871.328671329
Capital expenditures: 0
Operating cash flow: -2120439.8601398603
Depreciation & amortization: 674232.8671328671
Net tangible assets: 7824802.097902099
Owner earnings: -4410638.461538462
Return on net tangible assets (%): -56.367412317315924
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 336444046
Book value: 8519700.699300699
P/B ratio: 3.313856647513472
Market cap (USD): 28233066.7972028
Debt to equity: 0.22242245287187937
Current ratio: 0.03531410362059385
Quick ratio: 0.03531410362059385
Interest coverage ratio: -2.7204174201568487
COGS to revenue (%): 8656.428443167535
R&D to revenue (%): 2704.2018315676064
SG&A to revenue (%): 31257.50583587718
Free cash flow (dilution-adjusted): -2163873.426573427
Buyback yield (%): 0
Retained earnings: -37875327.97202797
Receivables turnover: 0.6290878282970912
Capitalized R&D asset: 591061.3486219663
ROCI (R&D-adjusted, %): -37.29145282315547
Rosenberg metric: -0.5554437362260319
FCF margin (%): -27781.818998024784
Revenue growth (%): -85.91612223393045
Rule of 40 score: -27867.735120258716
Financial ratios for JEV.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -172321.67832167834
Operating income: -1127215.3846153847
Net income: -1223355.9440559442
Capital expenditures: 0
Operating cash flow: -810601.3986013987
Depreciation & amortization: 172321.67832167834
Net tangible assets: 7928000
Owner earnings: -1051034.2657342658
Return on net tangible assets (%): -13.257243513298004
Buffett classification: The Gruesome
Stock price: 0.1048951048951049
Shares outstanding: 336444046
Book value: 8432101.3986014
P/B ratio: 4.1853544956607305
Market cap (USD): 35291333.496503495
Debt to equity: 0.20472063762320236
Current ratio: 0.20430449017592345
Quick ratio: 0.20430449017592345
Interest coverage ratio: -30.669317706153205
Free cash flow (dilution-adjusted): -1118402.7972027974
Buyback yield (%): 0
Retained earnings: -39098683.91608392
Receivables turnover: 0
Capitalized R&D asset: 14849.18181818182
ROCI (R&D-adjusted, %): -13.335426892719054
Rosenberg metric: 0.00233708353714909
Rule of 40 score: 0
Financial ratios for JEV.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -180419.70802919706
Operating income: -809292.7007299269
Net income: -1483078.8321167883
Capital expenditures: 0
Operating cash flow: -542640.8759124087
Depreciation & amortization: 180420.43795620438
Net tangible assets: 7459343.795620438
Owner earnings: -1302658.3941605838
Return on net tangible assets (%): -17.463444906848324
Buffett classification: The Gruesome
Stock price: 0.0948905109489051
Shares outstanding: 336444046
Book value: 7277824.087591241
P/B ratio: 4.386661046821667
Market cap (USD): 31925347.430656932
Debt to equity: 0.2584679045503594
Current ratio: 0.04577582093046289
Quick ratio: 0.04577582093046289
Interest coverage ratio: -25.04701125016943
Free cash flow (dilution-adjusted): -599516.7883211678
Buyback yield (%): 0
Retained earnings: -42294113.86861314
Receivables turnover: 0
Capitalized R&D asset: 8419.132867132868
ROCI (R&D-adjusted, %): -11.194489547161304
Rosenberg metric: -1.3001215315764878
Rule of 40 score: 0
Financial ratios for JEV.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -10033.093525179856
Operating income: -635641.7266187051
Net income: -801597.8417266188
Capital expenditures: 0
Operating cash flow: -116528.77697841727
Depreciation & amortization: 10032.374100719426
Net tangible assets: 6753394.964028778
Owner earnings: -791565.4676258994
Return on net tangible assets (%): -11.721000649926246
Buffett classification: The Gruesome
Stock price: 0.10071942446043167
Shares outstanding: 336444046
Book value: 6558971.942446044
P/B ratio: 5.166427143401027
Market cap (USD): 33886450.676258996
Debt to equity: 0.2852588869702448
Current ratio: 0.004877640135292208
Quick ratio: 0.004877640135292208
Interest coverage ratio: -18.13993881782906
Free cash flow (dilution-adjusted): -263839.5683453238
Buyback yield (%): 0
Retained earnings: -42487163.309352525
Receivables turnover: 0
Capitalized R&D asset: 13028.123408965137
ROCI (R&D-adjusted, %): -9.592252528367029
Rule of 40 score: 0
Financial ratios for JIN.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.233751425313569
Shares outstanding: 109258943
Market cap (USD): 134798376.654504
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JIN.OL — annual report dated 2022-12-31
Total revenue: 19572015.40436457
Gross profit: 5283697.047496791
Operating income: 4803465.982028241
Net income: -913093.7098844673
Capital expenditures: 9747753.530166881
Operating cash flow: 11340051.3478819
Depreciation & amortization: 5118100.128369705
Net tangible assets: 52720539.15275995
Owner earnings: -5542747.111681644
Return on net tangible assets (%): -10.513449218759513
Capex to operating income (%): 202.931665731313
Buffett classification: The Gruesome
Stock price: 0.7692307692307692
Shares outstanding: 109258943
Book value: 52777535.30166881
P/B ratio: 1.5924453517740014
Market cap (USD): 84045340.76923077
Debt to equity: 0.27284092650381747
Current ratio: 1.6389590466034314
Quick ratio: 1.5829638360367442
Interest coverage ratio: 10.883944153577662
COGS to revenue (%): 73.00381724450041
SG&A to revenue (%): 2.8603098395707893
Free cash flow (dilution-adjusted): -6709114.249037228
Buyback yield (%): 0
Retained earnings: 37579204.107830554
Inventory turnover: 37.18877380554627
Receivables turnover: 112.60413589364846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.717469542817425
FCF margin (%): -34.27911796728451
Rule of 40 score: -34.27911796728451
Financial ratios for JIN.OL — annual report dated 2023-12-31
Total revenue: 10482458.38668374
Gross profit: -2329833.546734955
Operating income: -3536747.759282971
Net income: -7049295.774647888
Capital expenditures: 883610.7554417414
Operating cash flow: 2041485.2752880922
Depreciation & amortization: 4736747.759282971
Net tangible assets: 44750064.020486556
Owner earnings: -3196158.7708066585
Return on net tangible assets (%): -7.142244018563769
Buffett classification: The Gruesome
Stock price: 0.5589390962671906
Shares outstanding: 109258943
Book value: 44805377.72087068
P/B ratio: 1.3629858281739706
Market cap (USD): 61069094.8595285
Debt to equity: 0.3352270454090818
Current ratio: 1.7532758780465205
Quick ratio: 1.7276434065424893
Interest coverage ratio: -4.430863009303819
COGS to revenue (%): 122.2260223774857
SG&A to revenue (%): 5.523525675477598
Free cash flow (dilution-adjusted): -1074135.723431498
Buyback yield (%): 0
Retained earnings: 29874135.723431498
Inventory turnover: 72.352856109906
Receivables turnover: 81.86800000000001
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.428534856334278
FCF margin (%): -10.246982948160452
Revenue growth (%): -46.44159954857717
Rule of 40 score: -56.688582496737624
Financial ratios for JIN.OL — quarterly report dated 2024-09-30
Capital expenditures: 4787387.387387387
Operating cash flow: 3285971.685971686
Buffett classification: The Gruesome
Stock price: 0.5734732824427481
Shares outstanding: 109258943
Market cap (USD): 62657084.67843512
Free cash flow (dilution-adjusted): -1501544.4015444017
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JIN.OL — annual report dated 2024-12-31
Total revenue: 20476804.12371134
Gross profit: 3211597.93814433
Operating income: 2406185.5670103095
Net income: 3093427.8350515463
Capital expenditures: 12568556.701030929
Operating cash flow: 9759407.216494845
Depreciation & amortization: 5694458.762886598
Net tangible assets: 47834020.6185567
Owner earnings: -3780670.103092784
Return on net tangible assets (%): -7.903726373413221
Capex to operating income (%): 522.343616109683
Buffett classification: The Gruesome
Stock price: 0.5246913580246914
P/E ratio: 18.53194134010147
Shares outstanding: 109258943
Book value: 47887886.59793815
P/B ratio: 1.1971132420256068
Market cap (USD): 57327223.17901234
Debt to equity: 0.35084900836898897
Current ratio: 1.2732354854447876
Quick ratio: 1.2181655553748576
Effective tax rate (%): 0
Interest coverage ratio: 3.065003282994091
COGS to revenue (%): 84.31592196349905
SG&A to revenue (%): 0.4808055380742605
Free cash flow (dilution-adjusted): -2811082.474226804
Buyback yield (%): 0
Retained earnings: 33160051.546391755
Inventory turnover: 49.45662606127722
Receivables turnover: 145.3796889295517
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9308646133765603
FCF margin (%): -13.728130899937065
Revenue growth (%): 95.34352885887716
Rule of 40 score: 81.6153979589401
Financial ratios for JIN.OL — quarterly report dated 2024-12-31
Total revenue: 5692783.5051546395
Gross profit: 170231.9587628866
Operating income: -263273.1958762887
Net income: 668685.5670103093
Capital expenditures: 3164819.587628866
Operating cash flow: 2440979.381443299
Net tangible assets: 47834020.6185567
Owner earnings: -2496134.020618557
Return on net tangible assets (%): -5.2183236707687675
Buffett classification: The Gruesome
Stock price: 0.5246913580246914
P/E ratio: 21.432802653167073
Shares outstanding: 109258943
Book value: 47887886.59793815
P/B ratio: 1.1971132420256068
Market cap (USD): 57327223.17901234
Debt to equity: 0.35084900836898897
Current ratio: 1.2732354854447876
Quick ratio: 1.2181655553748576
Effective tax rate (%): 0
Interest coverage ratio: -1.2963197969543148
COGS to revenue (%): 97.00968851865267
Free cash flow (dilution-adjusted): -723840.2061855671
Buyback yield (%): 0
Retained earnings: 33160051.546391755
Inventory turnover: 15.819490586932446
Receivables turnover: 40.417200365965236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.43009620850087366
FCF margin (%): -12.71504889532778
Rule of 40 score: -12.71504889532778
Financial ratios for JIN.OL — quarterly report dated 2025-03-31
Total revenue: 5051928.020565553
Gross profit: -109511.56812339331
Operating income: -358097.6863753213
Net income: 2194601.5424164524
Capital expenditures: 3767480.719794344
Operating cash flow: 3819794.3444730076
Net tangible assets: 49905655.526992284
Owner earnings: -1572879.1773778917
Return on net tangible assets (%): -3.151705274219221
Buffett classification: The Gruesome
Stock price: 0.5209923664122137
P/E ratio: 6.48444309423361
Shares outstanding: 109258943
Book value: 49959383.03341903
P/B ratio: 1.1393870742396872
Market cap (USD): 56923075.26526717
Debt to equity: 0.42370408866842985
Current ratio: 1.4318038060470244
Quick ratio: 1.380658919632046
Effective tax rate (%): 0
Interest coverage ratio: -1.0748456790123457
COGS to revenue (%): 102.16771829839202
Free cash flow (dilution-adjusted): 52313.62467866324
Buyback yield (%): 0
Retained earnings: 35269408.740359895
Inventory turnover: 14.189399293286218
Receivables turnover: 2.4376085338625653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5384948431290686
FCF margin (%): 1.0355180134337472
Revenue growth (%): -11.257331040409529
Rule of 40 score: -10.22181302697578
Financial ratios for JIN.OL — quarterly report dated 2025-06-30
Total revenue: 5126369.426751592
Gross profit: -78216.56050955414
Operating income: 81401.27388535033
Net income: -245222.92993630574
Capital expenditures: 151082.8025477707
Operating cash flow: 1840636.9426751593
Net tangible assets: 48717961.783439495
Owner earnings: -396305.7324840764
Return on net tangible assets (%): -0.8134694432532501
Capex to operating income (%): 185.60250391236306
Buffett classification: The Gruesome
Stock price: 0.5441906653426019
P/E ratio: 22.710557423145918
Shares outstanding: 109258943
Book value: 48771210.19108281
P/B ratio: 1.2191146508944017
Market cap (USD): 59457696.88579941
Debt to equity: 0.38588600354182007
Current ratio: 1.4993702275053138
Quick ratio: 1.443241753916398
Interest coverage ratio: 0.2992974238875878
COGS to revenue (%): 101.52576909696339
Free cash flow (dilution-adjusted): 961910.8280254777
Buyback yield (%): 0
Retained earnings: 34292101.910828024
Inventory turnover: 14.325385694249649
Receivables turnover: 2.3549859550561796
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.12824501018534315
FCF margin (%): 18.763977933502314
Revenue growth (%): 1.4735246797460508
Rule of 40 score: 20.237502613248367
Financial ratios for JIN.OL — quarterly report dated 2025-09-30
Total revenue: 5196015.424164524
Gross profit: 295629.82005141384
Operating income: 346401.02827763493
Net income: 10539.845758354755
Capital expenditures: 4404241.645244216
Operating cash flow: 2498200.5141388173
Net tangible assets: 49220565.55269923
Owner earnings: -4393701.799485861
Return on net tangible assets (%): -8.92655691812731
Capex to operating income (%): 1271.4285714285713
Buffett classification: The Gruesome
Stock price: 0.6092184368737474
P/E ratio: 25.32239996194839
Shares outstanding: 109258943
Book value: 49220565.55269924
P/B ratio: 1.352332337540311
Market cap (USD): 66562562.46893787
Debt to equity: 0.44357281634529
Current ratio: 3.0340333238740014
Quick ratio: 2.965824786151538
Effective tax rate (%): 0
Interest coverage ratio: 1.154670094258783
COGS to revenue (%): 94.3104514533086
Free cash flow (dilution-adjusted): 2029820.0514138816
Buyback yield (%): 0
Retained earnings: 34611182.5192802
Inventory turnover: 11.329866270430907
Receivables turnover: 3.4477611940298507
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5162667116205027
FCF margin (%): 39.064935064935064
Revenue growth (%): 1.3585832704426148
Rule of 40 score: 40.42351833537768
Financial ratios for JIN.OL — annual report dated 2025-12-31
Total revenue: 20242802.056555267
Gross profit: 1307455.0128534704
Operating income: 3075706.940874036
Net income: 1612339.3316195372
Capital expenditures: 255141.3881748072
Operating cash flow: 10230848.329048842
Depreciation & amortization: 7398071.979434447
Net tangible assets: 48821465.29562982
Owner earnings: 8755269.922879176
Return on net tangible assets (%): 17.933238729856168
Capex to operating income (%): 8.295373814200342
Buffett classification: The Great
Stock price: 0.5816733067729084
P/E ratio: 39.416647242293585
Shares outstanding: 109258943
Book value: 48877763.49614396
P/B ratio: 1.3002438353042995
Market cap (USD): 63553010.669322714
Debt to equity: 0.39702158209057276
Current ratio: 3.182973288410297
Quick ratio: 3.1160511770275927
Effective tax rate (%): 0
Interest coverage ratio: 2.66055147876362
COGS to revenue (%): 93.54113620633822
SG&A to revenue (%): 0.336531440291068
Free cash flow (dilution-adjusted): 897814.9100257069
Buyback yield (%): 0
Retained earnings: 34265809.76863753
Inventory turnover: 48.475485357025335
Receivables turnover: 89.89098173515981
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.744776660989088
FCF margin (%): 4.435230397043603
Revenue growth (%): -1.1427665457087
Rule of 40 score: 3.292463851334903
Financial ratios for JIN.OL — quarterly report dated 2025-12-31
Total revenue: 4822365.038560411
Gross profit: -7583.547557840617
Operating income: 139588.6889460154
Net income: -345372.7506426735
Capital expenditures: 534061.6966580977
Operating cash flow: 2055655.526992288
Net tangible assets: 48821465.29562982
Owner earnings: -879434.4473007713
Return on net tangible assets (%): -1.801327432463385
Capex to operating income (%): 382.59668508287297
Buffett classification: The Gruesome
Stock price: 0.5816733067729084
P/E ratio: 39.362781970389435
Shares outstanding: 109258943
Book value: 48877763.49614396
P/B ratio: 1.3002438353042995
Market cap (USD): 63553010.669322714
Debt to equity: 0.39702158209057276
Current ratio: 3.182973288410297
Quick ratio: 3.1160511770275927
Interest coverage ratio: 0.561821003621314
COGS to revenue (%): 100.15725784956555
Free cash flow (dilution-adjusted): -2154884.318766067
Buyback yield (%): 0
Retained earnings: 34265809.76863753
Inventory turnover: 12.364922671931557
Receivables turnover: 21.414383561643834
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.21533818604346816
FCF margin (%): -44.685217762140844
Revenue growth (%): -7.191094619666052
Rule of 40 score: -51.8763123818069